Norton Rose Fulbright advises Rothschild on recommended £999.6 million cash offer for Spire Healthcare by Ramsay Health Care

Global law firm Norton Rose Fulbright is advising N.M. Rothschild & Sons Limited as financial adviser to Ramsay Health Care Limited (Ramsay) and its wholly-owned subsidiary, Ramsay Health Care (UK) Limited, on the recommended cash offer for Spire Healthcare Group plc (Spire).

Under the terms of the offer, Spire shareholders will be entitled to receive 240 pence per share and the transaction values Spire’s entire issued and to be issued share capital at approximately £999.6 million.

Ramsay provides quality health care through a global network of clinical practice, teaching and research. Ramsay's global network extends across 10 countries, with over eight million admissions/patient visits per year to its facilities in over 500 locations, and is a leading producer of engineered solutions and materials for a variety of industries. Spire is a leading independent hospital group in the United Kingdom focused on private patients, with a strong collaborative partnership with the NHS.

The London-based team was led by partners Paul Whitelock, Kit McCarthy (both corporate) and James Dunnett (banking and finance), with support from senior associate Joshua Temkin and legal consultant Ksenia Orlova.